Stay updated on CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.

Latest updates to the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page
- CheckyesterdayChange DetectedDifference2%
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference2%
- Check16 days agoChange DetectedDifference3%
- Check23 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the addition of specific hematologic malignancies and collaborators, while significant details about the study's design and criteria have been removed.SummaryDifference27%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference2%
- Check38 days agoChange DetectedDifference1%
Stay in the know with updates to CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.